In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case evaluates patent law and the way it relate to our increasing knowledge of the Human Genome. The case issues deal with the possible penalties of Judge Sweet's decision for investors and biotechnology entrepreneurs.
PUBLICATION DATE: June 07, 2011 PRODUCT #: 811089-HCB-ENG
This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP
Related Case Solutions & Analyses:
Microsoft: Multimedia Publications (A)
Marcia Radosevich and Health Payment Review–1989 (A)
Health Stop Retail Medical Centers (A): Strategy
Cash Budgeting Cash Mangement
Mayers Tap Inc. (C)
Shaping the Future of Solar Power: Climate Change, Industrial Policy and Free Trade
Water Policy Priorities Along the U.S.-Mexico Border
Paragon Legal, A New Model (A)
Willow Creek Community Church, What Really Makes a Difference
StudyBlue (A)
